GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immunoclin Corp (GREY:IMCL) » Definitions » Notes Receivable

Immunoclin (Immunoclin) Notes Receivable : $0.00 Mil (As of Oct. 2014)


View and export this data going back to 2012. Start your Free Trial

What is Immunoclin Notes Receivable?

Immunoclin's Notes Receivable for the quarter that ended in Oct. 2014 was $0.00 Mil.


Immunoclin Notes Receivable Historical Data

The historical data trend for Immunoclin's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immunoclin Notes Receivable Chart

Immunoclin Annual Data
Trend Feb12 Jan13 Jan14
Notes Receivable
- - -

Immunoclin Quarterly Data
May11 Aug11 Nov11 Feb12 May12 Aug12 Nov12 Feb13 May13 Aug13 Nov13 Apr14 Jul14 Oct14
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Immunoclin Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.


Immunoclin Notes Receivable Related Terms

Thank you for viewing the detailed overview of Immunoclin's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Immunoclin (Immunoclin) Business Description

Traded in Other Exchanges
N/A
Address
9107 Wilshire Boulevard, Suite 450, Beverly Hills, CA, USA, 90210
Immunoclin Corp is engaged in immunology research and development skill to serve the pharmaceutical, biotechnology and food industries, providing comprehensive, clinical and basic science research expertise at a commercial scale and quality.

Immunoclin (Immunoclin) Headlines

No Headlines